id	sid	eid	entity	type
ajlm-1578	1	1	katherine e. hodkinson	PERSON
ajlm-1578	1	2	university of the witwatersrand	ORG
ajlm-1578	1	3	johannesburg	GPE
ajlm-1578	1	4	south africa	GPE
ajlm-1578	1	5	national health laboratory service	ORG
ajlm-1578	1	6	johannesburg	GPE
ajlm-1578	1	7	south africa	GPE
ajlm-1578	1	8	nikki bouwer department	ORG
ajlm-1578	1	9	university of the witwatersrand	ORG
ajlm-1578	1	10	johannesburg	GPE
ajlm-1578	1	11	south africa	GPE
ajlm-1578	1	12	national health laboratory service	ORG
ajlm-1578	1	13	johannesburg	GPE
ajlm-1578	1	14	south africa jenifer	GPE
ajlm-1578	1	15	university of the witwatersrand	ORG
ajlm-1578	1	16	johannesburg	GPE
ajlm-1578	1	17	south africa	GPE
ajlm-1578	1	18	national health laboratory service	ORG
ajlm-1578	1	19	johannesburg	GPE
ajlm-1578	1	20	south africa	GPE
ajlm-1578	1	21	hodkinson ke	PERSON
ajlm-1578	1	22	bouwer n	PERSON
ajlm-1578	1	23	j. south african study of blast	ORG
ajlm-1578	2	1	afr j	PERSON
ajlm-1578	3	1	2022;11(1	CARDINAL
ajlm-1578	3	2	1578	DATE
ajlm-1578	4	1	south african	NORP
ajlm-1578	4	2	katherine e. hodkinson	PERSON
ajlm-1578	4	3	nikki bouwer	PERSON
ajlm-1578	4	4	jenifer vaughan	PERSON
ajlm-1578	4	5	11	CARDINAL
ajlm-1578	4	6	22 feb. 2022	CARDINAL
ajlm-1578	4	7	31	CARDINAL
ajlm-1578	4	8	2022	CARDINAL
ajlm-1578	4	9	2022	CARDINAL
ajlm-1578	9	1	bc	ORG
ajlm-1578	9	2	cml	PERSON
ajlm-1578	9	3	one year	DATE
ajlm-1578	11	1	south africa	GPE
ajlm-1578	12	1	south africa	GPE
ajlm-1578	13	1	bc	ORG
ajlm-1578	13	2	charlotte	GPE
ajlm-1578	13	3	johannesburg academic hospital	ORG
ajlm-1578	13	4	johannesburg	GPE
ajlm-1578	13	5	south africa	GPE
ajlm-1578	13	6	april 2016	DATE
ajlm-1578	13	7	october 2019	DATE
ajlm-1578	14	1	bc-cml	PERSON
ajlm-1578	14	2	20%	PERCENT
ajlm-1578	16	1	twenty-two	CARDINAL
ajlm-1578	16	2	bc	ORG
ajlm-1578	16	3	34 years	DATE
ajlm-1578	17	1	20 (91%	PERCENT
ajlm-1578	17	2	two (9%	PERCENT
ajlm-1578	17	3	bcrabl1	GPE
ajlm-1578	18	1	14	CARDINAL
ajlm-1578	18	2	63.6%	PERCENT
ajlm-1578	18	3	six	CARDINAL
ajlm-1578	18	4	27.3%	PERCENT
ajlm-1578	18	5	two	CARDINAL
ajlm-1578	18	6	9.1%	PERCENT
ajlm-1578	19	1	72.7%	PERCENT
ajlm-1578	19	2	16	CARDINAL
ajlm-1578	21	1	bc-cml	LAW
ajlm-1578	21	2	south africa	GPE
ajlm-1578	22	1	south africa	GPE
ajlm-1578	22	2	bcrabl1	GPE
ajlm-1578	22	3	bcrabl1	GPE
ajlm-1578	24	1	9	CARDINAL
ajlm-1578	24	2	22	CARDINAL
ajlm-1578	24	3	1	CARDINAL
ajlm-1578	24	4	the world health organization	ORG
ajlm-1578	24	5	european	NORP
ajlm-1578	24	6	first	ORDINAL
ajlm-1578	25	1	first	ORDINAL
ajlm-1578	25	2	1998	DATE
ajlm-1578	27	1	second	ORDINAL
ajlm-1578	27	2	third	ORDINAL
ajlm-1578	27	3	the united states	GPE
ajlm-1578	28	1	bc	ORG
ajlm-1578	28	2	cml	PERSON
ajlm-1578	28	3	12 months	DATE
ajlm-1578	28	4	the united states	GPE
ajlm-1578	29	1	africa	LOC
ajlm-1578	29	2	second	ORDINAL
ajlm-1578	29	3	third	ORDINAL
ajlm-1578	29	4	bc-cml	ORG
ajlm-1578	30	1	bc	ORG
ajlm-1578	30	2	johannesburg	GPE
ajlm-1578	30	3	south africa	GPE
ajlm-1578	32	1	cambridge	GPE
ajlm-1578	32	2	massachusetts	GPE
ajlm-1578	32	3	united states	GPE
ajlm-1578	34	1	charlotte	GPE
ajlm-1578	34	2	johannesburg academic hospital	ORG
ajlm-1578	34	3	42 months	DATE
ajlm-1578	34	4	between 08 april 2016	DATE
ajlm-1578	34	5	16 october 2019	DATE
ajlm-1578	35	1	chris hani baragwanath academic hospital	PERSON
ajlm-1578	35	2	helen joseph	PERSON
ajlm-1578	37	1	microsoft corporation	ORG
ajlm-1578	37	2	santa rosa	GPE
ajlm-1578	37	3	california	GPE
ajlm-1578	37	4	united states	GPE
ajlm-1578	37	5	bc	ORG
ajlm-1578	38	1	cml	PERSON
ajlm-1578	39	1	14.1	CARDINAL
ajlm-1578	39	2	statacorp llc	ORG
ajlm-1578	39	3	texas	GPE
ajlm-1578	39	4	united states	GPE
ajlm-1578	41	1	two	CARDINAL
ajlm-1578	41	2	mann-whitney	PERSON
ajlm-1578	42	1	two	CARDINAL
ajlm-1578	42	2	0.05	CARDINAL
ajlm-1578	43	1	twenty-two	CARDINAL
ajlm-1578	43	2	bc	ORG
ajlm-1578	43	3	between 2016 and 2019	CARDINAL
ajlm-1578	44	1	cml	PRODUCT
ajlm-1578	45	1	34 years	DATE
ajlm-1578	45	2	21 years	DATE
ajlm-1578	45	3	two	CARDINAL
ajlm-1578	45	4	younger than 18 years	DATE
ajlm-1578	45	5	57%	PERCENT
ajlm-1578	45	6	12	CARDINAL
ajlm-1578	46	1	less than half	CARDINAL
ajlm-1578	46	2	50%	PERCENT
ajlm-1578	46	3	1	CARDINAL
ajlm-1578	47	1	1	CARDINAL
ajlm-1578	47	2	johannesburg	GPE
ajlm-1578	47	3	south africa	GPE
ajlm-1578	47	4	08	DATE
ajlm-1578	47	5	april 2016 to 16 october 2019	DATE
ajlm-1578	49	1	one	CARDINAL
ajlm-1578	49	2	three	CARDINAL
ajlm-1578	49	3	two	CARDINAL
ajlm-1578	51	1	twenty	CARDINAL
ajlm-1578	51	2	p210 bcr-abl1	ORG
ajlm-1578	51	3	two	CARDINAL
ajlm-1578	52	1	bc-cml	ORG
ajlm-1578	52	2	14	CARDINAL
ajlm-1578	52	3	63.6%	PERCENT
ajlm-1578	52	4	six	CARDINAL
ajlm-1578	52	5	27.3%	PERCENT
ajlm-1578	52	6	two	CARDINAL
ajlm-1578	52	7	9.1%	PERCENT
ajlm-1578	53	1	approximately two-thirds	CARDINAL
ajlm-1578	54	1	13	CARDINAL
ajlm-1578	54	2	one	CARDINAL
ajlm-1578	54	3	four	CARDINAL
ajlm-1578	54	4	two	CARDINAL
ajlm-1578	56	1	11	CARDINAL
ajlm-1578	56	2	16	CARDINAL
ajlm-1578	57	1	8	CARDINAL
ajlm-1578	57	2	five	CARDINAL
ajlm-1578	57	3	1	CARDINAL
ajlm-1578	58	1	one	CARDINAL
ajlm-1578	58	2	bc-cml	ORG
ajlm-1578	59	1	1	CARDINAL
ajlm-1578	59	2	johannesburg	GPE
ajlm-1578	59	3	south africa	GPE
ajlm-1578	59	4	08	DATE
ajlm-1578	59	5	april 2016 to 16 october 2019	DATE
ajlm-1578	60	1	16	CARDINAL
ajlm-1578	61	1	11	CARDINAL
ajlm-1578	62	1	five	CARDINAL
ajlm-1578	63	1	19	CARDINAL
ajlm-1578	63	2	8	CARDINAL
ajlm-1578	64	1	72.7%	PERCENT
ajlm-1578	64	2	16	CARDINAL
ajlm-1578	64	3	7 months	DATE
ajlm-1578	64	4	13.6 months	DATE
ajlm-1578	64	5	2	CARDINAL
ajlm-1578	65	1	bc-cml	LAW
ajlm-1578	66	1	five	CARDINAL
ajlm-1578	66	2	the first month	DATE
ajlm-1578	66	3	80%	PERCENT
ajlm-1578	66	4	four	CARDINAL
ajlm-1578	67	1	11	CARDINAL
ajlm-1578	67	2	6.7 months	DATE
ajlm-1578	67	3	4.5 months	DATE
ajlm-1578	67	4	two-thirds	CARDINAL
ajlm-1578	67	5	one-third	CARDINAL
ajlm-1578	68	1	6.1 months	DATE
ajlm-1578	68	2	3.3 months	DATE
ajlm-1578	69	1	2	CARDINAL
ajlm-1578	69	2	johannesburg	GPE
ajlm-1578	69	3	south africa	GPE
ajlm-1578	69	4	08	DATE
ajlm-1578	69	5	april 2016 to 16 october 2019	DATE
ajlm-1578	69	6	one	CARDINAL
ajlm-1578	70	1	22.7%	PERCENT
ajlm-1578	70	2	five	CARDINAL
ajlm-1578	70	3	25.6 months	DATE
ajlm-1578	70	4	12.5 months	DATE
ajlm-1578	71	1	80%	PERCENT
ajlm-1578	71	2	four	CARDINAL
ajlm-1578	71	3	second	ORDINAL
ajlm-1578	71	4	philadelphia	GPE
ajlm-1578	71	5	one	CARDINAL
ajlm-1578	71	6	three	CARDINAL
ajlm-1578	71	7	ccy	GPE
ajlm-1578	72	1	3	CARDINAL
ajlm-1578	73	1	one	CARDINAL
ajlm-1578	73	2	one year	DATE
ajlm-1578	74	1	3	CARDINAL
ajlm-1578	74	2	cml	PRODUCT
ajlm-1578	74	3	5	CARDINAL
ajlm-1578	74	4	johannesburg	GPE
ajlm-1578	74	5	south africa	GPE
ajlm-1578	74	6	08	DATE
ajlm-1578	74	7	april 2016 to 16 october 2019	DATE
ajlm-1578	75	1	1 to 5	CARDINAL
ajlm-1578	75	2	1	CARDINAL
ajlm-1578	75	3	51-year-old	DATE
ajlm-1578	75	4	2	CARDINAL
ajlm-1578	75	5	26-year-old	DATE
ajlm-1578	75	6	3	CARDINAL
ajlm-1578	75	7	19-year-old	DATE
ajlm-1578	75	8	4	CARDINAL
ajlm-1578	75	9	54-year-old	DATE
ajlm-1578	75	10	5	CARDINAL
ajlm-1578	75	11	37-year-old	DATE
ajlm-1578	76	1	2	CARDINAL
ajlm-1578	77	1	johannesburg	GPE
ajlm-1578	77	2	south africa	GPE
ajlm-1578	77	3	08	DATE
ajlm-1578	77	4	2016	CARDINAL
ajlm-1578	77	5	to16	ORG
ajlm-1578	77	6	october 2019	DATE
ajlm-1578	78	1	56%	PERCENT
ajlm-1578	78	2	16	CARDINAL
ajlm-1578	78	3	18%	PERCENT
ajlm-1578	78	4	five	CARDINAL
ajlm-1578	78	5	0.03	CARDINAL
ajlm-1578	79	1	37.3	CARDINAL
ajlm-1578	79	2	175.4	CARDINAL
ajlm-1578	79	3	144.2	CARDINAL
ajlm-1578	79	4	367.4	CARDINAL
ajlm-1578	79	5	0.52	CARDINAL
ajlm-1578	79	6	31	DATE
ajlm-1578	79	7	177	CARDINAL
ajlm-1578	79	8	101	CARDINAL
ajlm-1578	79	9	324	CARDINAL
ajlm-1578	79	10	0.54	CARDINAL
ajlm-1578	79	11	1	CARDINAL
ajlm-1578	80	1	bc-cml	LAW
ajlm-1578	80	2	south africa	GPE
ajlm-1578	81	1	the 61 years	DATE
ajlm-1578	81	2	setting.20,21,22	GPE
ajlm-1578	81	3	south african	NORP
ajlm-1578	84	1	south africa	GPE
ajlm-1578	85	1	bc-cml	ORG
ajlm-1578	86	1	bc-cml	ORG
ajlm-1578	86	2	cml per year.20,23	PERSON
ajlm-1578	87	1	bc-cml	ORG
ajlm-1578	87	2	around ~19%	PERCENT
ajlm-1578	87	3	35%.24,25	CARDINAL
ajlm-1578	87	4	taiwan	GPE
ajlm-1578	87	5	mexico	GPE
ajlm-1578	87	6	14%.24,25	CARDINAL
ajlm-1578	89	1	1%	PERCENT
ajlm-1578	89	2	cml	PRODUCT
ajlm-1578	90	1	greater than 80%	PERCENT
ajlm-1578	90	2	p190 bc-cml	PERSON
ajlm-1578	90	3	9.1%	PERCENT
ajlm-1578	92	1	south african	NORP
ajlm-1578	92	2	sector.27	GPE
ajlm-1578	92	3	cml	PRODUCT
ajlm-1578	93	1	second	ORDINAL
ajlm-1578	93	2	philadelphia	GPE
ajlm-1578	93	3	17q	CARDINAL
ajlm-1578	93	4	8	CARDINAL
ajlm-1578	93	5	19.29	CARDINAL
ajlm-1578	95	1	second	ORDINAL
ajlm-1578	95	2	philadelphia	GPE
ajlm-1578	97	1	ccy	ORG
ajlm-1578	98	1	ccy	GPE
ajlm-1578	100	1	10%	PERCENT
ajlm-1578	100	2	p190 bcr-abl1	ORG
ajlm-1578	100	3	102	CARDINAL
ajlm-1578	100	4	9	CARDINAL
ajlm-1578	100	5	first	ORDINAL
ajlm-1578	100	6	second	ORDINAL
ajlm-1578	100	7	dasatinib	PERSON
ajlm-1578	101	1	south african	NORP
ajlm-1578	101	2	first	ORDINAL
ajlm-1578	102	1	nilotinib	PERSON
ajlm-1578	102	2	second	ORDINAL
ajlm-1578	103	1	dasatinib	PERSON
ajlm-1578	104	1	second	ORDINAL
ajlm-1578	104	2	two	CARDINAL
ajlm-1578	104	3	third	ORDINAL
ajlm-1578	108	1	age ≥ 18 years	DATE
ajlm-1578	108	2	five years	DATE
ajlm-1578	108	3	2–3 years	DATE
ajlm-1578	108	4	bc-cml	ORG
ajlm-1578	108	5	monthly	DATE
ajlm-1578	108	6	4.5	CARDINAL
ajlm-1578	108	7	south african	NORP
ajlm-1578	109	1	about 40% to 60%	PERCENT
ajlm-1578	110	1	almost half	CARDINAL
ajlm-1578	110	2	7	CARDINAL
ajlm-1578	110	3	12 months	DATE
ajlm-1578	110	4	the first month	DATE
ajlm-1578	111	1	bc-cml	PERSON
ajlm-1578	111	2	bc-cml	ORG
ajlm-1578	113	1	bc	ORG
ajlm-1578	114	1	the united states	GPE
ajlm-1578	114	2	11.8 months	DATE
ajlm-1578	114	3	5.3 months	DATE
ajlm-1578	114	4	bc	ORG
ajlm-1578	114	5	bc-cml	ORG
ajlm-1578	114	6	5-year	DATE
ajlm-1578	114	7	60%	PERCENT
ajlm-1578	114	8	88%	PERCENT
ajlm-1578	114	9	first	ORDINAL
ajlm-1578	114	10	bc	ORG
ajlm-1578	114	11	10.9 months	DATE
ajlm-1578	114	12	bc	ORG
ajlm-1578	114	13	south african	NORP
ajlm-1578	115	1	cml	PRODUCT
ajlm-1578	115	2	second	ORDINAL
ajlm-1578	115	3	malignancies.46	PRODUCT
ajlm-1578	115	4	95%	PERCENT
ajlm-1578	115	5	8.6	CARDINAL
ajlm-1578	116	1	7.6–9.8	CARDINAL
ajlm-1578	116	2	1.7	CARDINAL
ajlm-1578	117	1	1.2–2.2	CARDINAL
ajlm-1578	117	2	second	ORDINAL
ajlm-1578	117	3	third	ORDINAL
ajlm-1578	117	4	second	ORDINAL
ajlm-1578	117	5	1.204	CARDINAL
ajlm-1578	117	6	95%	PERCENT
ajlm-1578	117	7	1.108–1.301	CARDINAL
ajlm-1578	119	1	second	ORDINAL
ajlm-1578	120	1	second	ORDINAL
ajlm-1578	121	1	bc-cml	ORG
ajlm-1578	123	1	advocay	GPE
ajlm-1578	126	1	ccy	ORG
ajlm-1578	126	2	bc	ORG
ajlm-1578	128	1	bc-cml	ORG
ajlm-1578	128	2	south africa	GPE
ajlm-1578	129	1	bc	ORG
ajlm-1578	131	1	bc-cml	ORG
ajlm-1578	132	1	7 months	DATE
ajlm-1578	133	1	johannesburg	GPE
ajlm-1578	133	2	helen joseph hospital	PERSON
ajlm-1578	135	1	n.b.	GPE
ajlm-1578	135	2	j.v.	GPE
ajlm-1578	136	1	j.v.	GPE
ajlm-1578	138	1	n.b.	GPE
ajlm-1578	138	2	j.v.	GPE
ajlm-1578	143	1	fialkow pj	PERSON
ajlm-1578	143	2	jacobson rj	PERSON
ajlm-1578	144	1	j med	PERSON
ajlm-1578	145	1	1977;63(1):125–130	CARDINAL
ajlm-1578	145	2	clein gp	PERSON
ajlm-1578	145	3	flemans	NORP
ajlm-1578	146	1	philadelphia	GPE
ajlm-1578	147	1	j haematol	PERSON
ajlm-1578	149	1	jm	ORG
ajlm-1578	149	2	fitzgerald ph	PERSON
ajlm-1578	149	3	gunz	GPE
ajlm-1578	152	1	https://doi.org/10.1136/bmj.1.5584.96 nowell	PERSON
ajlm-1578	154	1	blut	PERSON
ajlm-1578	155	1	1962;8:65–66	CARDINAL
ajlm-1578	156	1	rowley jd	PERSON
ajlm-1578	159	1	https://doi.org/10.1038/243290a0 wang es.	PERSON
ajlm-1578	160	1	hematology	ORG
ajlm-1578	161	1	2014;2014(1):14–20	ORDINAL
ajlm-1578	162	1	bursch s	ORG
ajlm-1578	162	2	350	CARDINAL
ajlm-1578	164	1	2002;16(1):53–59	CARDINAL
ajlm-1578	165	1	schmitt m	PERSON
ajlm-1578	165	2	bcr-abl	ORG
ajlm-1578	167	1	1994;83(5):1179–1187	CARDINAL
ajlm-1578	168	1	dowding cr	PERSON
ajlm-1578	168	2	riley gp	PERSON
ajlm-1578	168	3	goldman jm	PERSON
ajlm-1578	171	1	clarkson b. biology	PERSON
ajlm-1578	173	1	1988;25(1):1–19	CARDINAL
ajlm-1578	173	2	faderl s	PERSON
ajlm-1578	173	3	kantarjian	NORP
ajlm-1578	174	1	ann intern med	PERSON
ajlm-1578	175	1	1999;131(3):207–219	CARDINAL
ajlm-1578	175	2	arber da	PERSON
ajlm-1578	175	3	hasserjian	NORP
ajlm-1578	176	1	2016	DATE
ajlm-1578	176	2	the world health organization classification	ORG
ajlm-1578	178	1	2016;127(20):2391–2405	CARDINAL
ajlm-1578	178	2	2017	CARDINAL
ajlm-1578	180	1	2017;129(4):424–447	CARDINAL
ajlm-1578	180	2	https://doi.org/10.1182/blood-2016-08-733196 sokal je	PERSON
ajlm-1578	180	3	baccarani m	PERSON
ajlm-1578	180	4	tura s.	PERSON
ajlm-1578	181	1	semin hematol	PERSON
ajlm-1578	182	1	1988;25(1):49–61	DATE
ajlm-1578	182	2	ley tj	PERSON
ajlm-1578	182	3	mardis	GPE
ajlm-1578	186	1	guilhot	ORG
ajlm-1578	187	1	sti571	GPE
ajlm-1578	187	2	8-year	DATE
ajlm-1578	189	1	sasaki k	PERSON
ajlm-1578	189	2	strom ss	PERSON
ajlm-1578	189	3	six	CARDINAL
ajlm-1578	190	1	lancet	ORG
ajlm-1578	191	1	2015;2(5):e186	CARDINAL
ajlm-1578	192	1	baccarani m	PERSON
ajlm-1578	192	2	european	NORP
ajlm-1578	192	3	2013	DATE
ajlm-1578	194	1	2013;122(6):872–884	GPE
ajlm-1578	194	2	kantarjian	NORP
ajlm-1578	195	1	477	CARDINAL
ajlm-1578	197	1	2017;123(22):4391–4402	CARDINAL
ajlm-1578	198	1	patel m	PERSON
ajlm-1578	198	2	philip v	PERSON
ajlm-1578	198	3	ali n	PERSON
ajlm-1578	201	1	2012;36(11):1334–8	CARDINAL
ajlm-1578	202	1	oliver s	PERSON
ajlm-1578	202	2	samy f	PERSON
ajlm-1578	202	3	lawton s	PERSON
ajlm-1578	203	1	england	GPE
ajlm-1578	203	2	2001–2010	CARDINAL
ajlm-1578	203	3	england	GPE
ajlm-1578	203	4	wellington house	GPE
ajlm-1578	203	5	133	CARDINAL
ajlm-1578	203	6	london	GPE
ajlm-1578	203	7	phe	ORG
ajlm-1578	203	8	november 2014	DATE
ajlm-1578	204	1	khalidi hs	PERSON
ajlm-1578	204	2	brynes rk	PERSON
ajlm-1578	204	3	medeiros lj	PERSON
ajlm-1578	208	1	hellström k	PERSON
ajlm-1578	209	1	swedish	NORP
ajlm-1578	209	2	cml	PRODUCT
ajlm-1578	211	1	2013;122(7):1284–1292	CARDINAL
ajlm-1578	211	2	cárdenas r	PERSON
ajlm-1578	211	3	j. immunophenotypic	PERSON
ajlm-1578	213	1	1997;49(1):31–36. yen	MONEY
ajlm-1578	213	2	liu jh	PERSON
ajlm-1578	213	3	wang ws	PERSON
ajlm-1578	214	1	zhonghua yi xue za zhi	PERSON
ajlm-1578	214	2	taipei	GPE
ajlm-1578	216	1	kantarjian	NORP
ajlm-1578	216	2	jones	PERSON
ajlm-1578	216	3	p190 bcr-abl	ORG
ajlm-1578	218	1	https://doi.org/10.1182/blood-2009-02-204693 van rhee f	PERSON
ajlm-1578	218	2	hochhaus	PERSON
ajlm-1578	218	3	lin f	PERSON
ajlm-1578	219	1	p190 bcr-abl mrna	PERSON
ajlm-1578	221	1	1996;87(12):5213–5217	ORDINAL
ajlm-1578	222	1	issa gc	PERSON
ajlm-1578	222	2	kantarjian	NORP
ajlm-1578	222	3	gonzalez gn	PERSON
ajlm-1578	222	4	philadelphia	GPE
ajlm-1578	224	1	2017;130(19):2084–2091	CARDINAL
ajlm-1578	225	1	cml	PERSON
ajlm-1578	227	1	cervantes f	PERSON
ajlm-1578	228	1	philadelphia	GPE
ajlm-1578	231	1	takahashi k	PERSON
ajlm-1578	231	2	kantarjian	NORP
ajlm-1578	231	3	yang y	PERSON
ajlm-1578	234	1	https://doi.org/10.1002/cncr.30197 sasaki k	PERSON
ajlm-1578	236	1	clin lymphoma myeloma leuk	ORG
ajlm-1578	237	1	2016;16(3):152–162	CARDINAL
ajlm-1578	238	1	hochhaus	PERSON
ajlm-1578	239	1	ann oncol	PERSON
ajlm-1578	240	1	2017;28(suppl_4):iv41	CARDINAL
ajlm-1578	240	2	iv51	ORG
ajlm-1578	240	3	radich jp	PERSON
ajlm-1578	240	4	1.2019	CARDINAL
ajlm-1578	240	5	nccn clinical practice	ORG
ajlm-1578	242	1	2018;16(9):1108–1135	CARDINAL
ajlm-1578	244	1	berger m	PERSON
ajlm-1578	245	1	french	NORP
ajlm-1578	247	1	2018;124(14):2956–2963	CARDINAL
ajlm-1578	248	1	hughes tp	PERSON
ajlm-1578	248	2	ross dm	PERSON
ajlm-1578	250	1	2016;128(1):17–23	CARDINAL
ajlm-1578	250	2	r.	NORP
ajlm-1578	252	1	2012;120(4):737–747	TIME
ajlm-1578	252	2	600 mg	QUANTITY
ajlm-1578	252	3	6-year	DATE
ajlm-1578	253	1	haematologica	PERSON
ajlm-1578	255	1	kantarjian	NORP
ajlm-1578	256	1	imatinib mesylate	PERSON
ajlm-1578	256	2	sti571	GPE
ajlm-1578	256	3	philadelphia	GPE
ajlm-1578	258	1	hochhaus	PERSON
ajlm-1578	258	2	goh yt	PERSON
ajlm-1578	259	1	dasatinib	PERSON
ajlm-1578	259	2	2 years	DATE
ajlm-1578	259	3	3	CARDINAL
ajlm-1578	259	4	140	CARDINAL
ajlm-1578	259	5	70	CARDINAL
ajlm-1578	259	6	daily	DATE
ajlm-1578	261	1	2010;116(16):3852–3861	CARDINAL
ajlm-1578	262	1	giles fj	PERSON
ajlm-1578	262	2	coutre pd	FAC
ajlm-1578	262	3	48-month	DATE
ajlm-1578	264	1	2013;27(1):107–112	CARDINAL
ajlm-1578	265	1	https://doi.org/10.1038/leu.2012.181	PERSON
ajlm-1578	266	1	sct	ORG
ajlm-1578	266	2	german	NORP
ajlm-1578	267	1	2010;115(10):1880–1885	CARDINAL
ajlm-1578	267	2	blood-2009-08-237115	DATE
ajlm-1578	267	3	kim dw	PERSON
ajlm-1578	269	1	2008;22(12):2176–2183	CARDINAL
ajlm-1578	270	1	https://doi.org/10.1038/leu.2008.221 morita k	PERSON
ajlm-1578	270	2	kantarjian	NORP
ajlm-1578	270	3	sasaki k	PERSON
ajlm-1578	270	4	philadelphia	GPE
ajlm-1578	272	1	2021;127(15):2641–2647	CARDINAL
ajlm-1578	272	2	ravandi f	PERSON
ajlm-1578	272	3	bcr-abl	ORG
ajlm-1578	272	4	philadelphia	GPE
ajlm-1578	274	1	2020;143(6):567–573	CARDINAL
ajlm-1578	274	2	sasaki k	PERSON
ajlm-1578	274	3	kantarjian	NORP
ajlm-1578	274	4	second	ORDINAL
ajlm-1578	276	1	2019;109(5):545–552	ORG
ajlm-1578	276	2	https://doi.org/10.1007/s12185-019-02620-2	CARDINAL
ajlm-1578	276	3	kantarjian h	ORG